We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
1251
Monte Rosa Therapeutics
GLUE
$1.84B
$1K ﹤0.01%
203
HCM icon
1252
HUTCHMED
HCM
$1.93B
$1K ﹤0.01%
85
HUMA icon
1253
Humacyte
HUMA
$178M
$1K ﹤0.01%
301
IEUR icon
1254
iShares Core MSCI Europe ETF
IEUR
$8.86B
$1K ﹤0.01%
18
-11
-38% -$695
ITOS
1255
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
121
LXRX icon
1256
Lexicon Pharmaceuticals
LXRX
$1B
$1K ﹤0.01%
1,369
MESO
1257
Mesoblast
MESO
$1.87B
$1K ﹤0.01%
105
MRVI icon
1258
Maravai LifeSciences
MRVI
$1.02B
$1K ﹤0.01%
490
MXCT icon
1259
MaxCyte
MXCT
$111M
$1K ﹤0.01%
293
OABI icon
1260
OmniAb
OABI
$290M
$1K ﹤0.01%
475
OLMA icon
1261
Olema Pharmaceuticals
OLMA
$998M
$1K ﹤0.01%
224
OMER icon
1262
Omeros
OMER
$799M
$1K ﹤0.01%
191
PACB icon
1263
Pacific Biosciences
PACB
$435M
$1K ﹤0.01%
909
PAHC icon
1264
Phibro Animal Health
PAHC
$1.48B
$1K ﹤0.01%
38
PGEN icon
1265
Precigen
PGEN
$1.92B
$1K ﹤0.01%
708
PRME icon
1266
Prime Medicine
PRME
$547M
$1K ﹤0.01%
398
PRTA icon
1267
Prothena Corp
PRTA
$442M
$1K ﹤0.01%
195
RCKT icon
1268
Rocket Pharmaceuticals
RCKT
$348M
$1K ﹤0.01%
304
RGNX icon
1269
Regenxbio
RGNX
$607M
$1K ﹤0.01%
146
RIGL icon
1270
Rigel Pharmaceuticals
RIGL
$696M
$1K ﹤0.01%
80
RNAC icon
1271
Cartesian Therapeutics
RNAC
$226M
$1K ﹤0.01%
84
SVRA icon
1272
Savara
SVRA
$1.09B
$1K ﹤0.01%
553
TERN
1273
DELISTED
Terns Pharmaceuticals
TERN
$1K ﹤0.01%
151
THRD
1274
DELISTED
Third Harmonic Bio
THRD
$1K ﹤0.01%
149
TKNO icon
1275
Alpha Teknova
TKNO
$275M
$1K ﹤0.01%
300

Similar funds

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.